Actively Recruiting
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
Led by Bonafide Health · Updated on 2025-11-20
250
Participants Needed
1
Research Sites
72 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.
CONDITIONS
Official Title
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy biological females aged 50 to 70 years inclusive
- Body mass index (BMI) between 18.5 and 34.9 kg/m2 inclusive
- Self-reported natural postmenopause, defined as 12 months without menstrual cycle and menopausal symptoms for past 6 months
- Self-reported moderate or severe menopause-related joint discomfort rated 5 to 9 on a 0-10 scale
- Self-reported average of at least 4 hot flashes per day
- In good general health and able to consume the study product
- Agree to refrain from certain treatments during defined timeframes
- Have reliable, stable access to Wi-Fi and a smartphone or device
- Willing and able to consent, understand questionnaires, and complete all study procedures
You will not qualify if you...
- Lactating, pregnant, or planning pregnancy during the study
- Currently participating in another clinical trial
- Using treatments for menopausal or joint symptoms or other concomitant therapies as determined by the investigator
- Known allergy or intolerance to the study product or its components
- Use of glucosamine or chondroitin for joint symptoms in the 3 months before screening
- Received COVID-19 vaccine within 2 weeks before screening or during the study, current COVID-19 infection, or post-COVID-19 condition
- History of heart, kidney, liver disease, or active systemic infection such as Lyme disease, TB, or HIV
- History of cancer (except localized skin cancer without spread) within 2 years before screening
- Any significant disease or disorder that may affect safety or study participation as judged by the investigator
- History or presence of gastrointestinal, liver, or kidney disease affecting drug absorption or metabolism
- Gastrointestinal abnormalities or swallowing difficulties preventing digestion or swallowing
- Major surgery within 3 months before screening or planned during the study
- History of alcohol or substance abuse in past 5 years
- Evidence of inflammatory rheumatic or autoimmune diseases
- Chronic use of curcumin or curcuminoids supplements unless willing to undergo a 3-month washout
- Chronic use of pain medications or analgesics for joint pain unless willing to undergo a 2-week washout
- Severe joint or bone deformities
- Diagnosed bone fractures
- Candidate for surgical joint replacement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bonafide Health
Harrison, New York, United States, 10528
Actively Recruiting
Research Team
T
Trisha VanDusseldorp, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here